Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Pneumonia recovery reprograms the alveolar macrophage pool
Antoine Guillon, … , Lee J. Quinton, Joseph P. Mizgerd
Antoine Guillon, … , Lee J. Quinton, Joseph P. Mizgerd
Published January 28, 2020
Citation Information: JCI Insight. 2020;5(4):e133042. https://doi.org/10.1172/jci.insight.133042.
View: Text | PDF
Research Article Pulmonology

Pneumonia recovery reprograms the alveolar macrophage pool

  • Text
  • PDF
Abstract

Community-acquired pneumonia is a widespread disease with significant morbidity and mortality. Alveolar macrophages are tissue-resident lung cells that play a crucial role in innate immunity against bacteria that cause pneumonia. We hypothesized that alveolar macrophages display adaptive characteristics after resolution of bacterial pneumonia. We studied mice 1 to 6 months after self-limiting lung infections with Streptococcus pneumoniae, the most common cause of bacterial pneumonia. Alveolar macrophages, but not other myeloid cells, recovered from the lung showed long-term modifications of their surface marker phenotype. The remodeling of alveolar macrophages was (a) long-lasting (still observed 6 months after infection), (b) regionally localized (observed only in the affected lobe after lobar pneumonia), and (c) associated with macrophage-dependent enhanced protection against another pneumococcal serotype. Metabolomic and transcriptomic profiling revealed that alveolar macrophages of mice that recovered from pneumonia had new baseline activities and altered responses to infection that better resembled those of adult humans. The enhanced lung protection after mild and self-limiting bacterial respiratory infections includes a profound remodeling of the alveolar macrophage pool that is long-lasting; compartmentalized; and manifest across surface receptors, metabolites, and both resting and stimulated transcriptomes.

Authors

Antoine Guillon, Emad I. Arafa, Kimberly A. Barker, Anna C. Belkina, Ian Martin, Anukul T. Shenoy, Alicia K. Wooten, Carolina Lyon De Ana, Anqi Dai, Adam Labadorf, Jaileene Hernandez Escalante, Hans Dooms, Hélène Blasco, Katrina E. Traber, Matthew R. Jones, Lee J. Quinton, Joseph P. Mizgerd

×

Figure 6

Alveolar macrophage roles in defending naive and experienced lungs.

Options: View larger image (or click on image) Download as PowerPoint
Alveolar macrophage roles in defending naive and experienced lungs.
(A a...
(A and B) Liposomal clodronate effectively depleted mouse lungs of alveolar macrophages. Mice received i.n. liposomes that contained either PBS or clodronate (Clod). (A) Alveolar macrophage numbers were assessed using microscopy and cellular morphology with BAL samples from naive mice. Every individual symbol represents a single mouse, with horizontal lines showing the mean for the group. Asterisk (*) represents a significant (P < 0.05) difference using unpaired 2-tailed Student’s t test. Results include data pooled from 2 independent experiments. (B) Alveolar macrophage numbers were assessed using flow cytometry and surface marker characteristics with lung single-cell suspensions from naive or experienced mice. Every individual symbol represents a single mouse, with horizontal lines showing the mean for the group. Asterisks (*) represent significant (P < 0.05) differences from the naive PBS group using 1-way ANOVA and Holm-Šídák post hoc multiple-comparisons tests. Results include data from 2 independent experiments. (C and D) Naive or experienced mice received i.n. liposomes that contained either PBS or clodronate 72 hours prior to i.n. infections with either (C) a medium dose (0.75 × 106 CFU) or (D) a high dose (15 × 106 CFU) of serotype 3 pneumococcus. Infecting dose is depicted on graphs with a dotted line. Lung bacterial burdens were determined 24 hours after infection. Every individual symbol represents a single mouse, with horizontal lines showing mean for the group. Asterisks (*) indicate significant (P < 0.05) effects of clodronate using 2-way ANOVA on log-transformed data and Holm-Šídák post hoc multiple-comparisons tests (ns, not significant). Results include data from 3 independent experiments for each bacterial dose.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts